InspireMD logo
InspireMD
NSPR | NASDAQ
Chart Builder DCF Calculator
$0.60
-$0.04 (-6.85%)
At close: Nov 16, 2026, 4:00 PM ET
$0.61
+$0.01 (+2.00%)
After-hours: Nov 16, 2026, 5:49 PM ET

InspireMD Company Profile

Company profile explained

Company Profile

InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.

Key Executives

Name Position
Marvin L. Slosman President, Chief Executive Officer & Director
Amir Kohen Executive Vice President of Finance & Regional Manager
Donna DeChant Vice President of Human Resources & Organizational Development
Kathleen Kennedy Senior Vice President of Global Sales & Marketing
Michael A. Lawless CFO, Secretary & Treasurer
Pete Ligotti Executive Vice President & GM of North America
Peter A. Soukas Chief Medical Officer
Sol J. Barer Special Advisor to the Board
Sonali Dewan Senior Vice President of Regulatory & Medical Affairs and Quality Assurance
Vince Turturro Senior Vice President of Global Operations & Engineering

Latest SEC Filings

Date Type Title
Sep 23, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 21, 2026 8-K Current Report
Aug 17, 2026 8-K Current Report
Aug 14, 2026 10-Q Quarterly Report
Jul 29, 2026 8-K Current Report
Jul 23, 2026 8-K Current Report
Jul 02, 2026 8-K Current Report
Jun 11, 2026 8-K Current Report
View All SEC Filings ➞
InspireMD
InspireMD logo
Country United States
IPO Date Apr 12, 2011
Industry Medical - Devices
Sector Healthcare
Employees 127
CEO Marvin L. Slosman

Contact Details

6303 Waterford District Drive Miami, Florida 33126 United States

Stock Details

Ticker Symbol NSPR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001433607
CUSIP Number 45779A846
ISIN Number US45779A8466
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.